Clinical Trials Directory

Trials / Completed

CompletedNCT07389551

Comparison of Pregabalin Versus Gabapentin as Pre-emptive Analgesic

Comparison of Pregabalin Versus Gabapentin as Pre-emptive Analgesic in Patients Undergoing Orthopedic Surgeries Under Spinal Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
142 (actual)
Sponsor
Muhammad Aamir Latif · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

There are extensive gaps in the local data considering pregabalin versus gabapentin as pre-emptive analgesics in patients undergoing orthopedic surgeries under spinal anesthesia. Therefore, the current study was planned with the objective of comparing pregabalin versus gabapentin as pre-emptive analgesics in patients undergoing orthopedic surgeries under spinal anesthesia.

Detailed description

Since postoperative pain in orthopedic surgery, whether neuropathic or nociceptive, presents a significant challenge for both surgeons and patients, knowing the more effective gabapentinoid as a pre-emptive analgesic would help clinicians to offer prolonged timing of first rescue analgesia and less opioid consumption.

Conditions

Interventions

TypeNameDescription
DRUGGabapentinPatients were given a single oral dose of gabapentin 300 mg, with 30 ml of water, one hour prior to administration of spinal anesthesia.
DRUGPregabalinPatients received pregabalin 150 mg as a single oral dose, with 30 ml of water, one hour prior to administration of spinal anesthesia.

Timeline

Start date
2025-07-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2026-02-05
Last updated
2026-02-05

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07389551. Inclusion in this directory is not an endorsement.